HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yali Li Selected Research

RNA (Ribonucleic Acid)

11/2021Long non‑coding RNA FGD5‑AS1/microRNA‑133a‑3p upregulates aquaporin 1 to decrease the inflammatory response in LPS‑induced sepsis.
1/2016Transcriptome Analysis Highlights Defense and Signaling Pathways Mediated by Rice pi21 Gene with Partial Resistance to Magnaporthe oryzae.
11/2014[Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yali Li Research Topics

Disease

28Neoplasms (Cancer)
04/2024 - 01/2010
16Inflammation (Inflammations)
03/2024 - 01/2014
10Chronic Obstructive Pulmonary Disease (COPD)
05/2023 - 12/2015
9Infections
05/2021 - 05/2015
7Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2023 - 10/2020
7Neoplasm Metastasis (Metastasis)
10/2020 - 07/2002
7Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020 - 05/2009
6Carcinoma (Carcinomatosis)
04/2023 - 01/2010
6Hepatocellular Carcinoma (Hepatoma)
10/2022 - 07/2002
5Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2014
4Stroke (Strokes)
09/2023 - 08/2012
4Ovarian Neoplasms (Ovarian Cancer)
04/2023 - 07/2013
4Body Weight (Weight, Body)
01/2021 - 03/2019
4Breast Neoplasms (Breast Cancer)
01/2019 - 08/2011
4Endometriosis
11/2014 - 08/2012
3Pain (Aches)
03/2024 - 11/2016
3Bacterial Infections (Bacterial Infection)
01/2024 - 01/2017
3Wounds and Injuries (Trauma)
01/2024 - 02/2019
3Osteoarthritis
07/2023 - 01/2018
3Ischemic Stroke
06/2023 - 11/2016
3Insulin Resistance
01/2023 - 01/2019
3Fibrosis (Cirrhosis)
12/2022 - 11/2017
3Ovarian Epithelial Carcinoma
10/2022 - 11/2019
3Atherosclerosis
07/2022 - 01/2014
3Hypoxia (Hypoxemia)
01/2021 - 02/2014
3Melanoma (Melanoma, Malignant)
10/2020 - 02/2015
3Atypical Squamous Cells of the Cervix
09/2020 - 05/2009
3Amyloid Plaque
03/2020 - 01/2014
3Convalescence
01/2018 - 12/2015
3Carcinogenesis
10/2016 - 07/2002
3Lung Neoplasms (Lung Cancer)
05/2015 - 08/2013
3Uterine Cervical Dysplasia
01/2015 - 05/2009
2Diarrhea
02/2024 - 07/2019
2Migraine Disorders (Migraine)
10/2023 - 01/2023
2Colitis
06/2023 - 01/2021
2Hemorrhage
06/2023 - 02/2019
2Pathologic Constriction (Stenosis)
01/2023 - 04/2014
2Atrophy
12/2022 - 11/2017
2Brain Ischemia (Cerebral Ischemia)
09/2022 - 01/2019
2Epilepsy (Aura)
09/2022 - 01/2021
2Disease Progression
07/2022 - 01/2021
2Hypotension (Low Blood Pressure)
01/2022 - 01/2019
2Drug-Related Side Effects and Adverse Reactions
01/2022 - 09/2019
2Sepsis (Septicemia)
11/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
04/2024 - 07/2002
8Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2014
7Bleomycin (Blenoxane)FDA LinkGeneric
05/2023 - 10/2020
6DNA (Deoxyribonucleic Acid)IBA
09/2022 - 01/2013
6MicroRNAs (MicroRNA)IBA
05/2021 - 01/2012
6SmokeIBA
01/2021 - 11/2016
5Monoclonal AntibodiesIBA
10/2023 - 11/2013
5EnzymesIBA
07/2023 - 01/2017
5CytokinesIBA
01/2021 - 03/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2017
5C-Reactive ProteinIBA
10/2019 - 12/2015
4Oxygen (Dioxygen)IBA
05/2023 - 02/2014
4Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2018
4Caspase 3 (Caspase-3)IBA
11/2020 - 09/2017
4Interleukin-6 (Interleukin 6)IBA
07/2019 - 11/2016
3Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 07/2019
3Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2018
3Long Noncoding RNAIBA
10/2022 - 11/2019
3RNA (Ribonucleic Acid)IBA
11/2021 - 11/2014
3LipopolysaccharidesIBA
11/2021 - 11/2016
3LipidsIBA
02/2021 - 12/2014
3icariinIBA
01/2021 - 01/2014
3IridoidsIBA
01/2021 - 04/2018
3GlycosidesIBA
01/2021 - 04/2018
3pectolinarigeninIBA
10/2020 - 01/2019
3Messenger RNA (mRNA)IBA
05/2020 - 11/2014
3Amyloid (Amyloid Fibrils)IBA
03/2020 - 01/2014
3lobaplatinIBA
12/2019 - 02/2015
3phosphatidylcholine-ceramide phosphocholine transferaseIBA
02/2019 - 01/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 08/2012
2TeaIBA
02/2024 - 02/2021
2AcidsIBA
01/2024 - 10/2022
2ChitosanIBA
01/2024 - 01/2017
2eptinezumabIBA
10/2023 - 01/2023
2fremanezumabIBA
10/2023 - 01/2023
2galcanezumabIBA
10/2023 - 01/2023
2Calcitonin Gene-Related PeptideIBA
10/2023 - 01/2023
2erenumabIBA
10/2023 - 01/2023
2FlavonoidsIBA
12/2022 - 12/2014
2CollagenIBA
12/2022 - 01/2022
2Hydroxyl RadicalIBA
10/2022 - 08/2012
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2022 - 11/2019
2Sorafenib (BAY 43-9006)FDA Link
10/2022 - 01/2022
2Therapeutic UsesIBA
02/2022 - 01/2022
2SaponinsIBA
01/2022 - 04/2017
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
2Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
01/2022 - 01/2019

Therapy/Procedure

21Therapeutics
09/2023 - 07/2013
4Cesarean Section (Caesarean Section)
08/2023 - 08/2013
3Drug Therapy (Chemotherapy)
01/2022 - 03/2016
3Aftercare (After-Treatment)
11/2017 - 12/2014
2Hyperthermic Intraperitoneal Chemotherapy
04/2023 - 06/2021
2Radiofrequency Ablation
10/2022 - 01/2022
2Ligation
09/2022 - 10/2015
2Intraperitoneal Injections
02/2022 - 08/2012
2Anesthesia
01/2022 - 08/2021